TipRanks
Veri Medtech Holdings (VRHI)
OTHER OTC:VRHI
US Market
VRHI
Veri Medtech Holdings
RESEARCH TOOLSreports

Veri Medtech Holdings (VRHI) Ratios

5 Followers

Veri Medtech Holdings Ratios

VRHI's free cash flow for Q2 2026 was $0.73. For the 2026 fiscal year, VRHI's free cash flow was decreased by $ and operating cash flow was $-0.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
 0.05 0.05 1.12K 0.00 0.68
Quick Ratio
 0.05 0.05 1.12K 0.00 0.68
Cash Ratio
 <0.01 0.02 1.12K 0.00 0.68
Solvency Ratio
 -0.33 -0.87 -14.13 -0.63 -0.11
Operating Cash Flow Ratio
 0.09 0.13 -4.85K 0.00 -0.23
Short-Term Operating Cash Flow Coverage
 2.27 0.61 0.00 0.00 0.00
Net Current Asset Value
$ -2.78M$ -2.42M$ 22.59K$ -28.96K$ -86.80K
Leverage Ratios
Debt-to-Assets Ratio
 2.47 2.83 0.00 0.00 0.00
Debt-to-Equity Ratio
 -0.15 -0.22 0.00 0.00 0.00
Debt-to-Capital Ratio
 -0.18 -0.28 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 -0.13 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 -0.06 -0.08 1.03 1.28 4.49
Debt Service Coverage Ratio
 -5.48 -3.65 0.00 0.00 0.00
Interest Coverage Ratio
 -31.42 -33.28 0.00 0.00 0.00
Debt to Market Cap
 <0.01 0.02 0.00 0.00 0.00
Interest Debt Per Share
 0.06 0.07 0.00 0.00 0.00
Net Debt to EBITDA
 -0.46 -0.22 0.45 0.80 5.97
Profitability Margins
Gross Profit Margin
68.93%75.28%85.49%83.05%76.53%
EBIT Margin
-22.01%-20.89%-79.26%-156.70%-454.71%
EBITDA Margin
-9.86%-19.84%-76.75%-154.75%-62.99%
Operating Profit Margin
-22.01%-20.89%-79.26%-156.70%-454.71%
Pretax Profit Margin
-22.50%-21.53%-79.26%-156.70%-65.96%
Net Profit Margin
-22.50%-21.53%-79.26%-156.70%-65.96%
Continuous Operations Profit Margin
-22.50%-21.53%-79.26%-156.70%-454.71%
Net Income Per EBT
100.00%100.00%100.00%99.99%100.00%
EBT Per EBIT
102.24%103.05%100.00%100.00%14.51%
Return on Assets (ROA)
-1212.30%-1263.34%-37.20%-13.81%-9.29%
Return on Equity (ROE)
87.53%98.92%-38.17%-17.64%-41.75%
Return on Capital Employed (ROCE)
84.05%95.99%-37.20%-13.81%-287.82%
Return on Invested Capital (ROIC)
87.74%123.26%-37.20%-13.81%-287.82%
Return on Tangible Assets
-1212.30%-1263.34%-37.20%-13.81%-9.29%
Earnings Yield
-4.71%-9.34%-0.43%-0.15%-0.09%
Efficiency Ratios
Receivables Turnover
 0.00 1.64K 0.00 0.00 0.00
Payables Turnover
 1.55 1.87 472.29 0.00 0.04
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 203.72 181.58 10.38 0.43 0.82
Asset Turnover
 53.88 58.68 0.47 0.09 0.14
Working Capital Turnover Ratio
 -4.01 0.00 2.61 -0.94 1.75
Cash Conversion Cycle
 -234.83 -195.35 -0.77 0.00 -8.58K
Days of Sales Outstanding
 0.00 0.22 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 234.83 195.57 0.77 0.00 8.58K
Operating Cycle
 0.00 0.22 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 0.03 0.04 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
 0.03 0.04 >-0.01 >-0.01 >-0.01
CapEx Per Share
 <0.01 <0.01 0.00 0.00 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 0.99 1.00 1.00 1.02
Dividend Paid and CapEx Coverage Ratio
 32.88K 102.77 0.00 0.00 -62.15
Capital Expenditure Coverage Ratio
 32.88K 102.77 0.00 0.00 -62.15
Operating Cash Flow Coverage Ratio
 0.55 0.61 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.02 0.03 -1.49 -1.65 -1.26
Free Cash Flow Yield
0.52%1.26%-0.80%-0.16%-0.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -21.22 -10.43 -236.36 -685.71 -168.64
Price-to-Sales (P/S) Ratio
 4.78 2.30 185.04 1.06K 761.60
Price-to-Book (P/B) Ratio
 -16.10 -10.59 89.12 119.34 482.07
Price-to-Free Cash Flow (P/FCF) Ratio
 191.18 79.06 -124.22 -642.96 -595.72
Price-to-Operating Cash Flow Ratio
 191.19 78.29 -124.22 -642.96 -605.31
Price-to-Earnings Growth (PEG) Ratio
 0.14 0.00 -4.14 8.15 -2.02
Enterprise Value Multiple
 -48.88 -11.84 -240.64 -684.39 -1.20K
Enterprise Value
 44.42M 25.48M 14.43M 26.66M 37.36M
EV to EBITDA
 -48.88 -11.84 -240.64 -684.39 -1.20K
EV to Sales
 4.82 2.35 184.69 1.06K 757.84
EV to Free Cash Flow
 192.99 80.57 -123.99 -642.22 -592.78
EV to Operating Cash Flow
 192.99 79.79 -123.99 -642.22 -602.32
Tangible Book Value Per Share
 -0.34 -0.30 <0.01 <0.01 <0.01
Shareholders’ Equity Per Share
 -0.34 -0.30 <0.01 <0.01 <0.01
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 1.15 1.36 <0.01 <0.01 <0.01
Net Income Per Share
 -0.26 -0.29 >-0.01 >-0.01 >-0.01
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.02 1.03 1.00 1.00 0.15
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.04
SG&A to Revenue
 0.91 0.96 1.65 2.40 0.17
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.11 -0.14 1.88 1.05 1.91
Currency in USD